The influence of CYP2C19*2 and *17 on on-treatment platelet reactivity and bleeding events in patients undergoing elective coronary stenting

A.M. Harmsze; J.W. van Werkum; C.M. Hackeng; H.J.T. Ruven; J.C. Kelder; H.J. Bouman; N.J. Breet; J.M. ten Berg; O.H. Klungel; A. de Boer; V.H.M. Deneer

The influence of CYP2C192 and 17 on on-treatment platelet reactivity and bleeding events in patients undergoing elective coronary stenting

A.M. Harmsze, J.W. van Werkum, C.M. Hackeng, H.J.T. Ruven, J.C. Kelder, H.J. Bouman, N.J. Breet, J.M. ten Berg, O.H. Klungel, A. de Boer, V.H.M. Deneer

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	169-175
Number of pages	7
Journal	Pharmacogenetics and genomics
Volume	22
Publication status	Published - 2012

Keywords

Epidemiology
Farmacie(FARM)
Biomedische technologie en medicijnen
Ziekenhuisstructuur en organisatie van de gezondheidszorg
Public Health

Cite this

Harmsze, A. M., van Werkum, J. W., Hackeng, C. M., Ruven, H. J. T., Kelder, J. C., Bouman, H. J., Breet, N. J., ten Berg, J. M., Klungel, O. H., de Boer, A., & Deneer, V. H. M. (2012). The influence of CYP2C19*2 and *17 on on-treatment platelet reactivity and bleeding events in patients undergoing elective coronary stenting. Pharmacogenetics and genomics, 22, 169-175.

@article{25bb93a0bb7c4cbe9ea24771384e24b9,

title = "The influence of CYP2C19*2 and *17 on on-treatment platelet reactivity and bleeding events in patients undergoing elective coronary stenting",

keywords = "Epidemiology, Farmacie(FARM), Biomedische technologie en medicijnen, Ziekenhuisstructuur en organisatie van de gezondheidszorg, Public Health",

author = "A.M. Harmsze and {van Werkum}, J.W. and C.M. Hackeng and H.J.T. Ruven and J.C. Kelder and H.J. Bouman and N.J. Breet and {ten Berg}, J.M. and O.H. Klungel and {de Boer}, A. and V.H.M. Deneer",

year = "2012",

language = "English",

volume = "22",

pages = "169--175",

journal = "Pharmacogenetics and genomics",

issn = "1744-6872",

publisher = "Lippincott Williams & Wilkins",

}

TY - JOUR

T1 - The influence of CYP2C19*2 and *17 on on-treatment platelet reactivity and bleeding events in patients undergoing elective coronary stenting

AU - Harmsze, A.M.

AU - van Werkum, J.W.

AU - Hackeng, C.M.

AU - Ruven, H.J.T.

AU - Kelder, J.C.

AU - Bouman, H.J.

AU - Breet, N.J.

AU - ten Berg, J.M.

AU - Klungel, O.H.

AU - de Boer, A.

AU - Deneer, V.H.M.

PY - 2012

Y1 - 2012

KW - Epidemiology

KW - Farmacie(FARM)

KW - Biomedische technologie en medicijnen

KW - Ziekenhuisstructuur en organisatie van de gezondheidszorg

KW - Public Health

M3 - Article

SN - 1744-6872

VL - 22

SP - 169

EP - 175

JO - Pharmacogenetics and genomics

JF - Pharmacogenetics and genomics

ER -